Company Overview of Inviragen, Inc.
Inviragen, Inc. develops life-saving vaccines to protect against various infectious diseases in North America and internationally. It offers its products to protect against dengue viruses, as well as West Nile, swine-origin, chikungunya, plague/smallpox, and avian influenza diseases. The company's products also include INV21, a purified virus particle vaccine against hand, foot, and mouth disease. Inviragen, Inc. was founded in 2003 and is based in Fort Collins, Colorado. It has an additional office in Madison, Wisconsin. As of May 31, 2013, Inviragen, Inc. operates as a subsidiary of Takeda America Holdings, Inc.
2619 Midpoint Drive
Fort Collins, CO 80525
Founded in 2003
Key Executives for Inviragen, Inc.
Similar Private Companies By Industry
|Blue Ash Therapeutics, LLC||United States|
|St. Jon Laboratories Inc.||United States|
|Thar Pharmaceuticals, Inc.||United States|
|Atom Intermediate Holdings Inc.||United States|
|Sanofi-Synthelabo Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Inviragen, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.